• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产褥早期可溶性纤维蛋白单体复合物的含量及分布模式

Amount and distribution pattern of soluble fibrin monomer complexes during the early puerperium.

作者信息

Graeff G, Wiedemann A, von Hugo R, Hafter R

出版信息

Am J Obstet Gynecol. 1976 Jan 1;124(1):21-4. doi: 10.1016/0002-9378(76)90005-3.

DOI:10.1016/0002-9378(76)90005-3
PMID:1244743
Abstract

Soluble fibrin monomer complexes (SFMC) were determined in 12 patients following delivery, 2, 4, 6 days and 3 months post partum. Quantitative gel filtration (1 per cent agarose) of the beta-alanine-precipitated plasma samples yielded the relative (per cent of the total fibrinogen content) and absolute (milligrams per 100 ml. of plasma) amount of SFMC. During the early puerperium the amount of SFMC remained essentially constant, with average postpartum values of 6.3 +/- 1.2 per cent and 27.6 +/- 9.1 mg. per 100 ml. (mean and standard deviation). Three months after delivery the level of SFMC was significantly (p less than 0.001) decreased (3.3 +/- 1.3 per cent and 8.4 +/- 3.4 mg. per 100 ml.). The quantitative estimation of SFMC in the early puerperium as presented in this study indicates that a state of hypercoagulability can be evaluated by measuring the thrombin-mediated catabolic products of fibrinogen.

摘要

在12名产后妇女产后2天、4天、6天及3个月时测定可溶性纤维蛋白单体复合物(SFMC)。对经β-丙氨酸沉淀的血浆样本进行定量凝胶过滤(1%琼脂糖),得出SFMC的相对含量(占纤维蛋白原总含量的百分比)和绝对含量(每100毫升血浆中的毫克数)。在产褥早期,SFMC含量基本保持恒定,产后平均值为6.3±1.2%和每100毫升27.6±9.1毫克(均值和标准差)。分娩3个月后,SFMC水平显著降低(p<0.001)(每100毫升3.3±1.3%和8.4±3.4毫克)。本研究中对产褥早期SFMC的定量评估表明,通过测量凝血酶介导的纤维蛋白原分解产物可评估高凝状态。

相似文献

1
Amount and distribution pattern of soluble fibrin monomer complexes during the early puerperium.产褥早期可溶性纤维蛋白单体复合物的含量及分布模式
Am J Obstet Gynecol. 1976 Jan 1;124(1):21-4. doi: 10.1016/0002-9378(76)90005-3.
2
[Estimation of soluble fibrin monomer complexes for evaluation of hypercoagulability during pregnancy and delivery (author's transl)].[可溶性纤维蛋白单体复合物的测定用于评估妊娠和分娩期间的高凝状态(作者译)]
Geburtshilfe Frauenheilkd. 1975 Jul;35(7):518-25.
3
Evaluation of hypercoagulability in users of oral contraceptives.
Klin Wochenschr. 1977 Feb 15;55(4):175-9. doi: 10.1007/BF01469138.
4
Evaluation of hypercoagulability in septic abortion.感染性流产中高凝状态的评估。
Haemostasis. 1976;5(5):285-94. doi: 10.1159/000214147.
5
Rapid estimation of soluble fibrin monomer complexes by high performance liquid chromatography for the purpose of early detection of DIC.采用高效液相色谱法快速估算可溶性纤维蛋白单体复合物以早期检测弥散性血管内凝血。
Thromb Res. 1983 Jun 1;30(5):521-6. doi: 10.1016/0049-3848(83)90186-x.
6
Plasma soluble fibrin monomer complexes in nephrotic syndrome--with reference to hypoalbuminemia.肾病综合征中的血浆可溶性纤维蛋白单体复合物——关于低白蛋白血症
Tohoku J Exp Med. 1984 May;143(1):53-7. doi: 10.1620/tjem.143.53.
7
Proceedings: The evaluation of hypercoagulability and dic by quantitative gel filtration and by chain analysis of isolated soluble fibrin monomer complexes (SFMC).论文:通过定量凝胶过滤和对分离出的可溶性纤维蛋白单体复合物(SFMC)进行链分析来评估高凝状态和弥漫性血管内凝血(DIC)。
Thromb Diath Haemorrh. 1975 Sep 30;34(1):355.
8
Analysis of soluble fibrin complexes by agarose gel chromatography and protamine sulfate gelation.通过琼脂糖凝胶色谱法和硫酸鱼精蛋白凝胶化法分析可溶性纤维蛋白复合物。
Biochim Biophys Acta. 1976 Jan 20;420(1):69-80. doi: 10.1016/0005-2795(76)90345-7.
9
[Soluble fibrin monomer complexes in thromboembolism].[血栓栓塞中的可溶性纤维蛋白单体复合物]
Przegl Lek. 1982 Sep;39(8):551-3.
10
Plasma soluble fibrin monomer complexes in the development of diabetic retinopathy.血浆可溶性纤维蛋白单体复合物在糖尿病视网膜病变发展中的作用
Tohoku J Exp Med. 1982 Aug;137(4):409-13. doi: 10.1620/tjem.137.409.

引用本文的文献

1
Evaluation of hypercoagulability in users of oral contraceptives.
Klin Wochenschr. 1977 Feb 15;55(4):175-9. doi: 10.1007/BF01469138.
2
[Quantitative analysis of fibrinmonomer in Arwin-therapy (author's transl)].
Blut. 1978 Jan 20;36(1):9-14. doi: 10.1007/BF01002114.